Trademark: 97178382
Word
ILYRATOSI
Status
Pending
Status Code
732
Status Date
Wednesday, November 29, 2023
Serial Number
97178382
Mark Type
4000
Filing Date
Friday, December 17, 2021
Published for Opposition
Tuesday, June 28, 2022

Trademark Owner History
Biogen MA Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparation for the treatment of arthritis; anti-interleukin-6 (il-6) receptor monoclonal antibody for the treatment of disease caused by il-6 production; pharmaceutical preparations for the treatment of cytokine release syndrome; pharmaceutical preparations for the treatment of systemic sclerosis-associated interstitial lung disease

Trademark Events
Nov 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2023
Sou Extension 3 Granted
Nov 29, 2023
Sou Extension 3 Filed
Nov 29, 2023
Sou Teas Extension Received
Aug 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 14, 2023
Sou Extension 2 Granted
Aug 14, 2023
Sou Extension 2 Filed
Aug 14, 2023
Sou Teas Extension Received
Feb 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2023
Sou Extension 1 Granted
Feb 7, 2023
Sou Extension 1 Filed
Feb 7, 2023
Sou Teas Extension Received
Aug 23, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 28, 2022
Official Gazette Publication Confirmation E-Mailed
Jun 28, 2022
Published For Opposition
Jun 8, 2022
Notification Of Notice Of Publication E-Mailed
May 26, 2022
Approved For Pub - Principal Register
May 25, 2022
Teas/Email Correspondence Entered
May 25, 2022
Correspondence Received In Law Office
May 24, 2022
Assigned To Lie
May 18, 2022
Teas Response To Suspension Inquiry Received
Mar 14, 2022
Notification Of Letter Of Suspension E-Mailed
Mar 14, 2022
Letter Of Suspension E-Mailed
Mar 14, 2022
Suspension Letter Written
Mar 11, 2022
Teas/Email Correspondence Entered
Mar 11, 2022
Correspondence Received In Law Office
Mar 11, 2022
Teas Response To Office Action Received
Jan 10, 2022
Notification Of Non-Final Action E-Mailed
Jan 10, 2022
Non-Final Action E-Mailed
Jan 10, 2022
Non-Final Action Written
Jan 5, 2022
Assigned To Examiner
Dec 22, 2021
New Application Office Supplied Data Entered
Dec 21, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24